DUBLIN--(BUSINESS WIRE)--The "Recent Advances in Targeted Therapies" report has been added to ResearchAndMarkets.com's offering.
The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across targeted treatment strategies. High impact diseases such as hemophilia B, autism spectrum disorder, Alzheimer's disease, and cancer are highlighted. The corresponding clinical trials scenario is also depicted.
Key Topics Covered:
Innovations in Targeted Treatment Strategies
- Adeno-associated Virus Therapy Shows Promising Results in Hemophilia B Patients
- Uncovering the Role of Gut Microbiome in Autism Spectrum Disorder
- Novel Antibody Treatment for Alzheimer's Disease
- Selectively Targeting Cancer Genes
Clinical Trial Analysis and Key Contacts
- Clinical Trial Analysis for Loxo Oncology Inc.'s Candidates
- Key Contacts
For more information about this report visit https://www.researchandmarkets.com/research/bmmnsj/recent_advances?w=4
